AI-based Clinical Trial Solutions for Patient Matching Market Size Estimated to be Worth USD 2,876.37 Million By 2032, at 29.2% CAGR: Polaris Market Research

New York, NY, July 11, 2023 (GLOBE NEWSWIRE) — Polaris Market Research has published a new research report titled “AI-based Clinical Trial Solutions for Patient Matching Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Application; By End-Use (Pharmaceutical Companies, Academia, Others); Segment Forecast, 2023 – 2032” in its research database.

“As per the latest research analysis, the global AI-based clinical trial solutions for patient matching market size/share will be valued at roughly USD 253.13 Million in 2022, and its revenue is projected to reach about USD 2,876.37 Million By 2032. The market is forecasted to expand at a compound annual growth rate of approximately 29.2% between 2023 and 2032.”

What are AI-based Clinical Trial Solutions for Patient Matching? How Big is AI-based Clinical Trial Solutions for Patient Matching Market?

The process of finding and developing new drugs is expensive and time-consuming. Adopting AI-powered technologies for managing and executing clinical trials may decrease the duration and expense of the trial’s development cycle and boost productivity and accuracy.

Additionally, the AI-based clinical trial solutions for patient matching market are being driven by expanding private and public initiatives to boost the use of AI-powered technical solutions in clinical trial investigations. To support their clinical research projects, pharmaceutical and biotechnology industries quickly adopt AI-based tools and platforms. Businesses use these technologies for improved patient identification, recruiting, real-time monitoring, and engagement.
Request Sample Copy of AI-based Clinical Trial Solutions for Patient Matching Market Research Report @ https://polarismarketresearch.com/industry-analysis/ai-based-clinical-trial-solutions-for-patient-matching-market/request-for-sample

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)

Our Sample Report Covers:

• 2032 Updated Report Introduction, Overview, and In-depth industry analysis.
• 110+ Pages Research Report (Inclusion of Updated Research).
• Provide Chapter-wise guidance on Requests.
• 2023 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
• Includes Updated List of tables & figures.
• Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis.

Some of the Top Market Players Are:

• Unlearn.AI, Inc.
• Antidote Technologies Inc.
• Deep6.ai
• Mendel.ai
• Aris Global
• Deep Lens
• AmerisourceBergen Corporation
• Koneksa
• Microsoft Corporation
• GNS Healthcare

To Know Additional List of Key Players, Request Here to Download a Free Report PDF Brochure: https://polarismarketresearch.com/industry-analysis/ai-based-clinical-trial-solutions-for-patient-matching-market/request-for-sample

Prominent Growth Driving Factors

• Increased adoption of AI-powered technologies: Due to increased efforts from the public and private sectors to encourage the adoption of AI-powered technologies in clinical research, the AI-based clinical trial solutions for patient matching market size are expanding significantly. Companies in the pharmaceutical and biotechnology industries quickly adopt these platforms and solutions to support their research efforts. These technologies benefit patient engagement, identification, recruitment, and real-time monitoring.
• Growing demand for personalized medicine: The market is expanding due to the rising demand for personalized medication. Personalized medicine aims to offer customized therapies based on individual characteristics. Clinical trials are essential to the development of such treatments. In line with the demand for personalized medicine, AI-based patient matching solutions can quickly recognize patients with the characteristics or biomarkers necessary for a certain trial, hastening the development of targeted therapies.
• Rising prevalence of chronic diseases: The expansion of AI-based patient-matching solutions is further fueled by the increased prevalence of chronic diseases. Clinical trials are essential for creating new treatments since diseases like diabetes, cancer, and cardiovascular illnesses are becoming more prevalent worldwide. Researchers and pharmaceutical companies can quicken the development of new drugs and accelerate the introduction of advanced treatments to the AI-based Clinical Trial Solutions For Patient Matching Market by using AI-based solutions to efficiently identify people who fit the requirements for these trials.

Top Findings of the Report

• The rising incidence of chronic diseases and the rising demand for advanced medications are the primary reasons for the market expansion. To increase the number and success of clinical trials, artificial intelligence plays a significant role in patient selection and recruitment, trial design, venue selection, and patient monitoring.
• The AI-based clinical trial solutions for patient matching market segmentation are primarily based on the end-use, therapeutic application, and region.
• North America holds the largest share of the market in 2022.

Request for a Discount on this Report Before Purchase @ https://polarismarketresearch.com/industry-analysis/ai-based-clinical-trial-solutions-for-patient-matching-market/request-for-discount-pricing

Top Trends Influencing the Market

• Real-time monitoring and data analysis: AI algorithms can recognize patients more likely to benefit from a given intervention or at higher risk of doing so, enhancing trial results and resource allocation. The ability to monitor and analyze data in real-time results in more precise decisions and outcomes.
• Technological advancements: Due to developments in AI and machine learning technologies that have made it possible for sophisticated algorithms and tools to study large datasets to find patients who are suitable for clinical trials, the AI-based clinical trial solutions for patient matching market demand is expected to grow significantly over the coming years.

Segmental Analysis

• Oncology Sector Accounts for the Largest Revenue Share

In 2022, the oncology sector became the industry with the highest revenue generation, partly due to the rising cancer incidence worldwide. As a result, the industry has seen a noticeable rise in clinical studies, which indicates a favorable trend.

Moreover, leading pharmaceutical corporations have partnered with AI development businesses to exploit AI’s potential in cancer research. These collaborations seek to use AI-based technologies created expressly for pharmaceutical purposes.

• Pharmaceutical Companies Sector Holds the Largest Revenue Share

Pharmaceutical businesses are the market segment with the highest AI-based clinical trial solutions for patient matching market share. This is due to the increased attention being paid to utilizing AI-based technologies to speed up the drug development process, improve the identification of biomarkers, and discover novel therapeutic targets. Pharmaceutical businesses increasingly use AI’s capabilities after realizing its promise in these fields.

Inquire more about this report before purchase @ https://polarismarketresearch.com/industry-analysis/ai-based-clinical-trial-solutions-for-patient-matching-market/inquire-before-buying

(Inquire about a report quote OR available discount offers to the sales team before purchase.)

AI-based Clinical Trial Solutions for Patient Matching Market: Report Scope

Geographical Overview

North America: In 2022, North America held the biggest market share and is expected to maintain strong growth throughout the projected period. The market expansion is facilitated by the presence of well-known enterprises in the area and the increase in AI startups—furthermore, the sector benefits from the many registered clinical studies conducted in North America.

Asia Pacific: During the projection period, the AI-based clinical trial solutions for the patient matching market in Asia Pacific are expected to develop at the fastest compound annual growth rate (CAGR). This development can be linked to the region’s pro-AI governmental actions and the rising acceptance of AI-based therapeutic solutions.

Browse the Detail Report “AI-based Clinical Trial Solutions for Patient Matching Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Application; By End-Use (Pharmaceutical Companies, Academia, Others); Segment Forecast, 2023 – 2032” with in-depth TOC: https://polarismarketresearch.com/industry-analysis/ai-based-clinical-trial-solutions-for-patient-matching-market

For Additional Information OR Media Enquiry, Please Mail At: [email protected]

Recent Developments

• The Bridge2AI program, which will include participants from different groups and focus on providing various tools, resources, and data for developing an AI strategy, was introduced by The NIH in September 2022.
• Qureight received a seed investment of USD 1.50 million in February 2022 for its AI-based platform, which reduces the cost of medication by speeding up clinical studies and reducing their duration.

The Report Answers Questions Such As

• What are the AI-based clinical trial solutions for patient matching market growth?
• What is the estimated value of the market?
• Who are the AI-based clinical trial solutions for patient matching market key players?
• Which segment accounts for the largest market share?
• Which region holds significant AI-based clinical trial solutions for patient matching market share?
• What is the expected CAGR of the industry during the forecast period?

Polaris Market Research has segmented the AI-based Clinical Trial Solutions for Patient Matching market report based on therapeutic application, end-use, and region:

By Therapeutic Application Outlook

• Oncology
• Cardiovascular Diseases
• Metabolic Diseases
• Neurological Diseases or Conditions
• Infectious Diseases
• Others

By End-Use

• Pharmaceutical Companies
• Academia
• Others

By Region Outlook

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Browse More Research Reports:

About Polaris Market Research:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR’s customers.

Contact:

Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-929 297-9727
Email: [email protected]
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

Blog: https://polarismarketresearch.medium.com | https://polarisnewsblog.com